Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Monaldi Arch Chest Dis ; 88(1): 912, 2018 May 28.
Article in English | MEDLINE | ID: mdl-29806447

ABSTRACT

Breast reconstruction is a very popular surgical intervention performed either for cosmetic reasons or after oncological resections. Even though silicone is considered to be an inert material, there are side effects that have been reported, such as silicone lymphadenopathy. In the case reported herein, a silicone lymphadenopathy of the internal mammary and the anterior mediastinal lymph nodes were revealed after a thymectomy for autoimmune myasthenia gravis. Silicone lymphadenopathy should always be part of the differential diagnosis of enlarged lymph nodes, in patients with previous cosmetic or oncoplastic surgery with the use of silicone gel breast implants. Special attention should be paid in case of previous breast cancer in order to rule out metastasis.

2.
Monaldi Arch Chest Dis ; 88(3): 913, 2018 09 04.
Article in English | MEDLINE | ID: mdl-30183162

ABSTRACT

The familial occurrence of thymic pathology, even though rare, is widely reported in the literature and mainly concerns cases of familial autoimmune myasthenia gravis. Other less frequent cases of familial occurrence of thymoma, thymic carcinoid and thymic hyperplasia have been described. It seems that the familial occurrence is poorly recorded and thus its prevalence is underestimated. We report two families whose members presented different forms of thymic pathology and discuss the necessity of screening programs in family members of patients presenting a thymic lesion.


Subject(s)
Carcinoma/diagnostic imaging , Family , Thymoma/diagnostic imaging , Thymus Hyperplasia/diagnostic imaging , Thymus Neoplasms/diagnostic imaging , Adult , Aged , Carcinoma/pathology , Carcinoma/surgery , Early Detection of Cancer , Female , Fluorodeoxyglucose F18 , Humans , Male , Mass Screening , Middle Aged , Positron-Emission Tomography , Radiopharmaceuticals , Thymoma/pathology , Thymoma/surgery , Thymus Hyperplasia/pathology , Thymus Hyperplasia/surgery , Thymus Neoplasms/pathology , Thymus Neoplasms/surgery
3.
Ann Gastroenterol ; 32(5): 482-488, 2019.
Article in English | MEDLINE | ID: mdl-31474795

ABSTRACT

BACKGROUND: Endoscopic full-thickness resection (EFTR) using the full-thickness resection device (FTRD®) is an invasive treatment for colorectal lesions not resectable by conventional endoscopic techniques. This study presents the first Greek experience of the FTRD® procedure, assessing the efficacy and safety of EFTR. METHODS: We conducted a retrospective analysis of 17 consecutive patients treated with the FTRD® at 2 referral centers from October 2015 through December 2018. The indications included difficult adenomas (non-lifting and/or at difficult locations), early adenocarcinomas and subepithelial tumors. Primary endpoints were technical success and R0 resection. RESULTS: Technical success and R0 resection were achieved in 82.3% procedures (14/17) and in 87.5% of those with difficult adenomas (8 patients). In the subgroup with carcinomas (n=3), the rate of technical success and R0 resection was 66.6%, while in the subgroup with subepithelial tumors (n=6) the rate was 83.3%. Technical success and R0 resection were significantly lower for lesions >20 mm vs. ≤20 mm (P=0.0429). In the 17 patients a total of 3 adverse events occurred (17.6%) and one of the patients underwent laparoscopic appendectomy because of EFTR around the appendix. CONCLUSIONS: Our study showed favorable results concerning EFTR feasibility, efficacy and safety, especially for lesions ≤20 mm, non-lifting adenomas, and subepithelial tumors. Technical success, R0 resection, and adverse events rates were comparable with previously published data. Larger randomized studies are needed to better define the clinical benefit and long-term outcomes of EFTR in selected patients.

4.
Urol Oncol ; 34(4): 165.e11-8, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26652134

ABSTRACT

OBJECTIVE: To explore the correlation between the expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in prostate cancer (PCa) and its clinicopathological data including tumor grade and clinical stage. METHODS: The expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin was examined in 157 cases of PCa and adjacent normal prostatic tissue by immunohistochemical assay, and the correlation with clinicopathological features was analyzed. RESULTS: Expressions of α5-integrin, α7-integrin, and Ε-cadherin in PCa were lower than those in normal prostatic tissues (P<0.05). N-cadherin expression was higher in cancer prostatic tissue than in normal prostatic tissues (P<0.05). The reduced expression of α5-integrin, α7-integrin, and Ε-cadherin was related to Gleason score, pathological stage, lymph node metastasis, and prostate-specific antigen level, but it was not associated with positive surgical margins and patient age. The increased expression of N-cadherin was related to Gleason score, pathological stage, lymph node metastasis, and prostate-specific antigen level, but not to age and positive surgical margins. The expression of E-cadherin was highly negatively correlated with that of N-cadherin and also positively correlated with that of α5-integrin and α7-integrin. CONCLUSION: The reduced expression of α5-integrin, α7-integrin, and Ε-cadherin and abnormal expression of N-cadherin play an important role in the occurrence and development of PCa. The results indicate that these have potential values in the diagnosis and are predictable indices in the proliferation of PCa.


Subject(s)
Antigens, CD/biosynthesis , Biomarkers, Tumor/biosynthesis , Cadherins/biosynthesis , Integrin alpha Chains/biosynthesis , Integrin alpha5/biosynthesis , Prostatic Neoplasms/metabolism , Aged , Humans , Male , Middle Aged , Prostatic Neoplasms/pathology
6.
Med Sci Monit ; 10(5): CR213-7, 2004 May.
Article in English | MEDLINE | ID: mdl-15114272

ABSTRACT

BACKGROUND: The purpose of our research was to investigate the effect of supplementation with vitamin C and E on ocular surface cytology specimens and related parameters in diabetic patients. MATERIAL/METHODS: 60 patients were enrolled in the study. The patients were given vitamin C (1000 mg/day) and vitamin E (400 IU/day) for 10 days. Conjunctival brush cytology specimens were obtained before and after treatment. Schirmer tests, break-up time and ocular ferning tests were also performed. RESULTS: Goblet cell densities were 50 cells/per field before and 59 cells/per field after supplementation (p=0.002). The stage of squamous metaplasia was 1.12+/-0.42 before and 0.88+/-0.41 after supplementation (p=0.011). The changes were accompanied with improved values for the Schirmer test (p<0.001), break up time (p=0.001), and ocular ferning (p<0.001). CONCLUSIONS: Diabetes mellitus is associated with increased oxidative stress. Our study suggests that supplementation with antioxidant vitamins C and E probably plays an important role in improving the ocular surface milieu.


Subject(s)
Ascorbic Acid/therapeutic use , Conjunctiva/drug effects , Diabetes Mellitus, Type 2/drug therapy , Tears/drug effects , Vitamin E/therapeutic use , Antioxidants/metabolism , Conjunctival Diseases/pathology , Goblet Cells/metabolism , Humans , Oxidative Stress , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL